Azithromycin versus doxycycline: management of female urogenital and rectal Chlamydia trachomatis infections

About this item

Title

Azithromycin versus doxycycline: management of female urogenital and rectal Chlamydia trachomatis infections

Content partner

New Zealand Medical Association

Collection

The New Zealand Medical Journal

Description

Chlamydia trachomatis infection is the most common sexually transmitted infection (STI) internationally, with the greatest burden of disease in young sexually active adults, and it is associated with pelvic inflammatory disease, chronic pelvic pain, infertility and pregnancy complications.[[1]] The purpose of this review is to inform prescribing practice for the management of female urogenital and anorectal chlamydia. Of note, where we refer t...

Format

Article

Date created

7 october 2022

Creator

Elissa M McDonald / Rachel T Woodcock / Felix S F Ram

URL

https://journal.nzma.org.nz/journal-articles/azithromycin-versus-doxycycline-management-of-female...

What is the copyright status of this item?

All Rights Reserved

This item is all rights reserved, which means you'll have to get permission from New Zealand Medical Association before using it.

What can I do with this item?

You must always check with New Zealand Medical Association to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

No sharing

You may not copy and/or share this item with others without further permission. This includes posting it on your blog, using it in a presentation, or any other public use.

No modifying

You are not allowed to adapt or remix this item into any other works.

No commercial use

You may not use this item commercially.